Gigantomastia Bilateral Induced Efavirenz: A Case Report

Authors

  • Amos Pongbulaan
  • Erwin Astha Triyono

DOI:

https://doi.org/10.37506/ijfmt.v15i3.15437

Keywords:

Gigantomastia, Efavirenz, HIV, HAART

Abstract

The prognosis of HIV-infection has improved dramatically since the introduction of Highly Active
Antiretroviral Therapy (HAART). With the need for a lifelong treatment, the longterm side effect of
antiretroviral agents is an emergent issue of concern. Gigantomastia is a rare condition characterized by
excessive breast growth. It may occur spontaneously, during puberty or pregnancy, or while taking certain
medications. HAART medications which probably associated with gigantomastia is efavirenz. A 25-yearold woman with HIV-infection who developed bilateral gigantomastia while receiving efavirenz-based
HAART regimens. The diagnosis was made after other possible causes of disease-induced gigantomastia
were exclude and confirmed by mammography. Surgical treatment has been considered after failure of
medical treatment. Although it is rare, physicians should be aware so that a timely diagnosis can be made.
In most cases, only conservative treatment is sufficient, but in severe cases surgical intervention might be
required.

Author Biographies

  • Amos Pongbulaan

    Resident, Department of Internal Medicine,  Faculty of Medicine Airlangga University, Surabaya Indonesia

  • Erwin Astha Triyono

    2Doctor at Division of Tropical and Infection, Department of Internal
    Medicine, Dr. Soetomo Hospital – Faculty of Medicine Airlangga University, Surabaya Indonesia

Downloads

Published

2021-05-17

How to Cite

Gigantomastia Bilateral Induced Efavirenz: A Case Report. (2021). Indian Journal of Forensic Medicine & Toxicology, 15(3), 956-960. https://doi.org/10.37506/ijfmt.v15i3.15437